Palvella Therapeutics (PVLA) Other Working Capital Changes (2016 - 2024)
Historic Other Working Capital Changes for Palvella Therapeutics (PVLA) over the last 11 years, with Q4 2024 value amounting to $1.3 million.
- Palvella Therapeutics' Other Working Capital Changes rose 10369.75% to $1.3 million in Q4 2024 from the same period last year, while for Dec 2024 it was $1.5 million, marking a year-over-year increase of 65054.95%. This contributed to the annual value of $1.5 million for FY2024, which is 65054.95% up from last year.
- According to the latest figures from Q4 2024, Palvella Therapeutics' Other Working Capital Changes is $1.3 million, which was up 10369.75% from $134000.0 recorded in Q3 2024.
- Over the past 5 years, Palvella Therapeutics' Other Working Capital Changes peaked at $53.3 million during Q4 2021, and registered a low of -$47.6 million during Q4 2022.
- Over the past 5 years, Palvella Therapeutics' median Other Working Capital Changes value was $307000.0 (recorded in 2022), while the average stood at -$694800.0.
- Its Other Working Capital Changes has fluctuated over the past 5 years, first crashed by 73954.38% in 2021, then soared by 334102.0% in 2023.
- Palvella Therapeutics' Other Working Capital Changes (Quarter) stood at -$29.3 million in 2020, then skyrocketed by 282.14% to $53.3 million in 2021, then plummeted by 189.18% to -$47.6 million in 2022, then rose by 28.37% to -$34.1 million in 2023, then soared by 103.7% to $1.3 million in 2024.
- Its Other Working Capital Changes stands at $1.3 million for Q4 2024, versus $134000.0 for Q3 2024 and $163000.0 for Q2 2024.